{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:46:35Z","timestamp":1794807995604,"version":"4.9.1"},"reference-count":106,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.heliyon.2023.e16187","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T07:31:43Z","timestamp":1684135903000},"page":"e16187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["The use of clinical scales and PROMs in headache disorders and migraine, summarizing their dissemination and operationalization"],"prefix":"10.1016","volume":"9","author":[{"given":"P\u0131nar","family":"Yalinay Dikmen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aynur","family":"Ozge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e16187_bib1","series-title":"Lifting the Burden, Atlas of Headache Disorders and Resources in the World 2011","year":"2011"},{"key":"10.1016\/j.heliyon.2023.e16187_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s10194-022-01402-2","article-title":"The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates","volume":"23","author":"Stovner","year":"2022","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib3","first-page":"1","article-title":"The international classification of headache disorders, 3rd edition","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib4","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"GBD 2016 Headache Collaborators, Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2023.e16187_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","article-title":"Katsarava, and on behalf of Lifting the Burden: the Global Campaign against Headache. Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019","volume":"21","author":"Steiner","year":"2020","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/0333102419828967","article-title":"International headache society clinical trials committee, guidelines of the international headache society for controlled trials of acute treatment of migraine attacks in in adults","volume":"39","author":"Diener","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1177\/0333102420941839","article-title":"International headache society clinical trials committee, guidelines of the international headache society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults","volume":"40","author":"Diener","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/0333102418758283","article-title":"International headache society clinical trials committee, guidelines of the international headache society for controlled trials of preventive treatment of migraine attacks in chronic migraine in adults","volume":"38","author":"Tassorelli","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib9","unstructured":"Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims, Guidance for Industry (fda.gov) accessed 10.26.22."},{"key":"10.1016\/j.heliyon.2023.e16187_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2288-6-2","article-title":"Protocol of the COSMIN study: COnsensus-based standards for the selection of health measurement instruments","volume":"6","author":"Mokkink","year":"2006","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.heliyon.2023.e16187_bib11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","article-title":"The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes","volume":"63","author":"Mokkink","year":"2010","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.heliyon.2023.e16187_bib12","doi-asserted-by":"crossref","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD group, STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2023.e16187_bib13","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2023.e16187_bib14","unstructured":"https:\/\/www.strobe-statement.org\/."},{"key":"10.1016\/j.heliyon.2023.e16187_bib15","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.heliyon.2023.e16187_bib16","series-title":"Introduction. Health Measurement Scales","author":"Streiner","year":"2008"},{"key":"10.1016\/j.heliyon.2023.e16187_bib17","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1177\/0333102417731348","article-title":"Assessing the impact of headaches and the outcomes of treatment: a systematic review of patient-reported outcome measures (PROMs)","volume":"38","author":"Haywood","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1526-4610.2006.00289.x","article-title":"Validation of the revised patient perception of migraine questionnaire: measuring satisfaction with acute migraine treatment","volume":"46","author":"Revicki","year":"2006","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/head.14229","article-title":"Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: the Activity Impairment in Migraine Diary","volume":"62","author":"Lipton","year":"2022","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s10194-016-0674-1","article-title":"The development and validation of the Cluster Headache Quality of life scale (CHQ)","volume":"17","author":"Abu Bakar","year":"2016","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/0333102412449933","article-title":"Minimal clinically important change on the Headache Impact Test-6 questionnaire in patients with chronic tension-type headache","volume":"32","author":"Castien","year":"2012","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/2168479015622667","article-title":"Interpreting change in scores on patient-reported outcome instruments","volume":"50","author":"Coon","year":"2016","journal-title":"Ther. Innov. Regul. Sci."},{"key":"10.1016\/j.heliyon.2023.e16187_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Contr. Clin. Trials"},{"key":"10.1016\/j.heliyon.2023.e16187_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jclinepi.2005.05.010","article-title":"Four methods of estimating the minimal important difference score were compared to establish a clinically significant change in Headache Impact Test","volume":"59","author":"Coeytaux","year":"2006","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.heliyon.2023.e16187_bib25","first-page":"300","article-title":"Reliability and validity of Turkish version of headache impact test (HIT-6) in patients with migraine","volume":"58","author":"Dikmen","year":"2020","journal-title":"Noro. Psikiyatr. Ars"},{"key":"10.1016\/j.heliyon.2023.e16187_bib26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1212\/WNL.0000000000006697","article-title":"Red and orange flags for secondary headaches in clinical practice","volume":"92","author":"Do","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e16187_bib27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/head.14054","article-title":"Green Flags and headache: a concept study using the Delphi method","volume":"61","author":"Pohl","year":"2021","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11916-021-00995-8","article-title":"Updates in the diagnostic approach of headache","volume":"25","author":"Do","year":"2021","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.heliyon.2023.e16187_bib29","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1468-2982.2006.01093.x","article-title":"Headache in United States emergency departments","volume":"26","author":"Goldstein","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1526-4610.2003.03088.x","article-title":"A rapid and sensitive paradigm for screening headache patients in primary care settings","volume":"43","author":"Maizels","year":"2003","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1212\/01.WNL.0000078940.53438.83","article-title":"ID Migraine validation study A self-administered screener for migraine in primary care","volume":"61","author":"Lipton","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e16187_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1526-4610.2007.00946.x","article-title":"Results of screening with the brief headache screen compared with a modified ID Migraine","volume":"48","author":"Maizels","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib33","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1526-4610.2011.01916.x","article-title":"Diagnostic accuracy of the ID migraine: a systematic review and meta-analysis","volume":"51","author":"Cousins","year":"2011","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib34","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1177\/03331024211018138","article-title":"A brief diagnostic screen for cluster headache: creation and initial validation of the Erwin Test for Cluster Headache","volume":"41","author":"Parakramaweera","year":"2021","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib35","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1526-4610.2005.00265.x","article-title":"Development and validation of the migraine screen questionnaire (MS-Q)","volume":"45","author":"L\u00e1inez","year":"2005","journal-title":"Headache J. Head Face Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2377-10-39","article-title":"New uses of the migraine screen questionnaire (MS-Q): validation in the primary care setting and ability to detect hidden migraine. MS-Q in primary care","volume":"10","author":"L\u00e1inez","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.heliyon.2023.e16187_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/0333102415583982","article-title":"Improving the detection of chronic migraine: development and validation of identify chronic migraine (ID-CM)","volume":"36","author":"Lipton","year":"2016","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/head.14035","article-title":"Evaluation of the 6\u2010item Identify Chronic Migraine screener in a large medical group","volume":"61","author":"Pavlovic","year":"2021","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s10194-022-01402-2","article-title":"The global prevalence of headache: an update, with analysis of influences of methodological factors on prevalence estimates","volume":"23","author":"Stovner","year":"2022","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib40","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/03331024221082061","article-title":"The burden and health care use of patients with migraine and tension-type headache in post-conflict area of Serbia","volume":"42","author":"Milosevic","year":"2022","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib41","series-title":"Societal Impact of Headache, Springer Nature Switzerland AG","year":"2019"},{"key":"10.1016\/j.heliyon.2023.e16187_bib42","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1023\/A:1026119331193","article-title":"A six-item short-form survey for measuring headache impact: the HIT-6","volume":"12","author":"Kosinski","year":"2003","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.heliyon.2023.e16187_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0333102413497599","article-title":"What is a clinically relevant change on the HIT-6 questionnaire? An estimation in a primary-care population of migraine patients","volume":"34","author":"Smelt","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-2982.1999.019002107.x","article-title":"Reliability of the migraine disability assessment score in a population-based sample of headache sufferers","volume":"19","author":"Stewart","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1212\/WNL.56.suppl_1.S20","article-title":"Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability","volume":"56","author":"Stewart","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e16187_bib46","series-title":"How Much Change in Headache-Related Disability Is Clinically Meaningful? Estimating Minimally Important Difference (MID) or Change in MIDAS Using Data from the AMPP Study [Abstract]","author":"Lipton","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e16187_bib47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s10194-021-01339-y","article-title":"Minimal important change and responsiveness of the migraine disability assessment score (MIDAS) questionnaire","volume":"22","author":"Carvalho","year":"2021","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib48","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1212\/WNL.57.11.2034","article-title":"PedMIDAS: development of a questionnaire to assess disability of migraines in children","volume":"57","author":"Hershey","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e16187_bib49","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1526-4610.2006.00633.x","article-title":"Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes","volume":"47","author":"Silberstein","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib50","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1468-2982.2000.00117.x","article-title":"International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: second edition","volume":"20","author":"Tfelt-Hansen","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib51","first-page":"28","article-title":"Psychometric properties of the migraine physical function impact diary (MPFID)","volume":"25","author":"Kawata","year":"2016","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.heliyon.2023.e16187_bib52","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/head.13162","article-title":"Psychometric evaluation of a novel instrument assessing the impact of migraine on physical functioning: the migraine physical function impact","volume":"57","author":"Kawata","year":"2017","journal-title":"Diary, Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib53","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12955-017-0799-1","article-title":"Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID)","volume":"15","author":"Hareendran","year":"2017","journal-title":"Health Qual. Life Outcome"},{"key":"10.1016\/j.heliyon.2023.e16187_bib54","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","article-title":"Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1\u2013eliciting concepts for a new PRO instrument","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.heliyon.2023.e16187_bib55","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","article-title":"Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 2\u2013assessing respondent understanding","volume":"14","author":"Patrick","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.heliyon.2023.e16187_bib56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jama.1989.03430070073033","article-title":"The Medical Outcome Study: an application of methods for monitoring the results of medical care","volume":"262","author":"Tarlov","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2023.e16187_bib57","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1526-4610.1993.hed3307351.x","article-title":"Quality of life and well-being of headache patients: measurement by the Medical Outcomes Study instrument","volume":"33","author":"Solomon","year":"1993","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib58","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1526-4610.1994.hed3406337.x","article-title":"Measuring the functional status and well-being of patients with migraine headache","volume":"34","author":"Osterhaus","year":"1994","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib59","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1212\/WNL.55.5.629","article-title":"Migraine, quality of life and depression. A population-based case-control study","volume":"55","author":"Lipton","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e16187_bib60","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1212\/WNL.55.5.624","article-title":"The impact of migraine on quality of life in the general population, the GEM study","volume":"55","author":"Terwindt","year":"2000","journal-title":"Neurol."},{"key":"10.1016\/j.heliyon.2023.e16187_bib61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQoL - a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Pol."},{"key":"10.1016\/j.heliyon.2023.e16187_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/PROM.S222597","article-title":"Patient-reported outcome in two chronic diseases: a comparison of quality of life and response profiles in severe migraine and severe asthma","volume":"11","author":"Lucas","year":"2020","journal-title":"Patient Relat. Outcome Meas."},{"key":"10.1016\/j.heliyon.2023.e16187_bib63","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11136-010-9783-5","article-title":"EuroQoL (EQ-5D) health utility scores for patients with migraine","volume":"20","author":"Xu","year":"2011","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.heliyon.2023.e16187_bib64","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-Item Short Form Health Survey (SF-36). I: conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"key":"10.1016\/j.heliyon.2023.e16187_bib65","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1468-2982.2003.00546.x","article-title":"Migraine headache disability and health-related quality-of-life: a population-based case-control study from England","volume":"23","author":"Lipton","year":"2003","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1526-4610.1998.3804295.x","article-title":"Development and validation of the migraine-specific quality of life questionnaire","volume":"38","author":"Jhidran","year":"1998","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib67","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1526-4610.2000.00030.x","article-title":"Validity and reliability of the migraine-specific quality of life questionnaire (MSQ Version 2.1)","volume":"40","author":"Martin","year":"2000","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib68","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1468-2982.2009.01852.x","article-title":"Minimal important differences in the migraine-specific quality of life questionnaire (MSQ) version 2.1","volume":"29","author":"Cole","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.heliyon.2023.e16187_bib69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s10194-021-01366-9","article-title":"In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention, A real-world evidence study","volume":"22","author":"Alpuente","year":"2021","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib70","first-page":"770","article-title":"The migraine prevention questionnaire (MPQ): development and validation","volume":"47","author":"Lipton","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib71","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1016\/S0149-2918(03)80345-4","article-title":"Measuring satisfaction with migraine treatment: expectations, importance, outcomes, and global ratings","volume":"25","author":"Patrick","year":"2003","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e16187_bib72","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1526-4610.2012.02099.x","article-title":"The development of a survey to measure completeness of response to migraine therapy","volume":"52","author":"Conn","year":"2012","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s10194-020-1084-y","article-title":"Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study","volume":"21","author":"Buse","year":"2020","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib74","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13760-014-0312-0","article-title":"The relationships between migraine, depression, anxiety, stress, and sleep disturbances","volume":"115","author":"Yalinay Dikmen","year":"2015","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.heliyon.2023.e16187_bib75","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s13760-017-0856-x","article-title":"Relationship between MIDAS, depression, anxiety and alexithymia in migraine patients","volume":"120","author":"Yalinay Dikmen","year":"2010","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.heliyon.2023.e16187_bib76","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10194-010-0282-4","article-title":"Migraine and psychiatric comorbidity: a review of clinical findings","volume":"12","author":"Antonaci","year":"2011","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib77","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s10194-022-01388-x","article-title":"The bidirectional temporal relationship between headache and affective disorders: longitudinal data from the HUNT studies","volume":"23","author":"Giri","year":"2022","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib78","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1129-2377-14-79","article-title":"Headache and comorbidity in children and adolescents","volume":"14","author":"Bellini","year":"2013","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib79","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/ane.13014","article-title":"Multimorbidity in patients with chronic migraine and medication overuse headache","volume":"138","author":"D'Amico","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.heliyon.2023.e16187_bib80","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/head.13459","article-title":"Migraine progression: a systematic review","volume":"59","author":"Buse","year":"2019","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib81","doi-asserted-by":"crossref","first-page":"e2224","DOI":"10.1212\/WNL.0000000000008589","article-title":"Migraine progression in subgroups of migraine based on comorbidities: results of the CaMEO study","volume":"93","author":"Lipton","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2023.e16187_bib82","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jad.2009.06.019","article-title":"A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population","volume":"122","author":"L\u00f6we","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.heliyon.2023.e16187_bib83","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Group PHQPCS, Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2023.e16187_bib84","first-page":"n2183","article-title":"Depression Screening Data (DEPRESSD) PHQ Group Accuracy of the Patient Health Questionnaire-9 for screening to detect major depression: updated systematic review and individual participant data meta-analysis","volume":"375","author":"Negeri","year":"2021","journal-title":"BMJ (Clinical research ed)."},{"key":"10.1016\/j.heliyon.2023.e16187_bib85","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12888-017-1450-8","article-title":"Utility of the PHQ-9 to identify major depressive disorder in adult patients in Spanish primary care centers","volume":"17","author":"Mu\u00f1oz-Navarro","year":"2017","journal-title":"BMC Psychiatr."},{"key":"10.1016\/j.heliyon.2023.e16187_bib86","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s10194-015-0552-2","article-title":"Validation of the patient health questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine","volume":"16","author":"Seo","year":"2015","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib87","series-title":"Beck Depression Inventory\u2013II (BDI-II) [Database Record], APA PsycTests","author":"Beck","year":"1996"},{"key":"10.1016\/j.heliyon.2023.e16187_bib88","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.heliyon.2023.e16187_bib89","first-page":"3","article-title":"State-trait anxiety inventory for adults (STAI-AD)","volume":"5","author":"Spielberger","year":"1971","journal-title":"APA PsycTests"},{"key":"10.1016\/j.heliyon.2023.e16187_bib90","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.heliyon.2023.e16187_bib91","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s10194-015-0583-8","article-title":"Validation of the generalized anxiety disorder-7 (GAD-7) and GAD-2 in patients with migraine","volume":"16","author":"Seo","year":"2015","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib92","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.heliyon.2023.e16187_bib93","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s10194-021-01241-7","article-title":"Demoralization predicts suicidality in patients with cluster headache","volume":"22","author":"Koo","year":"2021","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib94","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fneur.2019.00228","article-title":"Association of suicide risk with headache frequency among migraine patients with and without aura","volume":"10","author":"Lin","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.heliyon.2023.e16187_bib95","series-title":"ECDEU Assessment Manual for Psychopharmacology","year":"1976"},{"key":"10.1016\/j.heliyon.2023.e16187_bib96","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s10194-021-01243-5","article-title":"Disability, quality of life, productivity impairment and employer costs of migraine in the workplace","volume":"22","author":"Shimizu","year":"2021","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib97","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s10194-015-0579-4","article-title":"Productivity losses attributable to headache, and their attempted recovery, in a heavy-manufacturing workforce in Turkey: implications for employers and politicians","volume":"16","author":"Selekler","year":"2015","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.heliyon.2023.e16187_bib98","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s41687-019-0138-x","article-title":"Content validity of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome","volume":"3","author":"Speck","year":"2019","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.heliyon.2023.e16187_bib99","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/head.13497","article-title":"Psychometric validation of the role function restrictive domain of the migraine specific quality-of-life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine","volume":"59","author":"Speck","year":"2019","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib100","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/head.14031","article-title":"Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine","volume":"61","author":"Speck","year":"2021","journal-title":"Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib101","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/215206Orig1s000lbl.pdf."},{"key":"10.1016\/j.heliyon.2023.e16187_bib102","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/761063s000lbl.pdf."},{"key":"10.1016\/j.heliyon.2023.e16187_bib103","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/head.13162","article-title":"Psychometric evaluation of a novel instrument assessing the impact of migraine on physical functioning: the migraine physical function impact","volume":"57","author":"Kawata","year":"2017","journal-title":"Diary, Headache"},{"key":"10.1016\/j.heliyon.2023.e16187_bib104","unstructured":"https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/aimovig-epar-product-information_en.pdf."},{"key":"10.1016\/j.heliyon.2023.e16187_bib105","unstructured":"Emgality, INN-galcanezumab (europa.eu); https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/emgality-epar-product-information_en.pdf."},{"key":"10.1016\/j.heliyon.2023.e16187_bib106","series-title":"Clinical Scales for Headache Disorders","isbn-type":"print","year":"2023","ISBN":"https:\/\/id.crossref.org\/isbn\/9783031259388"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023033947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023033947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:59:46Z","timestamp":1773395986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023033947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":106,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2405844023033947"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16187","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of clinical scales and PROMs in headache disorders and migraine, summarizing their dissemination and operationalization","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e16187"}}